Table 3.

Top discriminators between Group-A versus Group-B/C leiomyosarcomas based on label-free MS/MS analysis

AccessionDescriptiont-StatisticPq-value
O15145ARPC3_HUMAN6.6903910641.49E−050.011147884
P61077-2;P61077-3;P62837;P62837-2UB2D3_HUMAN7.1080722817.96E−060.011147884
Q92841;Q92841-1;Q92841-2DDX17_HUMAN6.232817653.05E−050.011147884
Q99623PHB2_HUMAN6.465440752.11E−050.011147884
Q01469FABP5_HUMAN6.037859444.18E−050.011371082
O75694NU155_HUMAN5.6783771517.56E−050.013915789
O96019ACL6A_HUMAN5.476684570.0001062780.013915789
P62750RL23A_HUMAN5.4298491480.0001151130.013915789
P62917RL8_HUMAN5.7616024026.58E−050.013915789
P63244GBLP_HUMAN5.4417910580.0001127890.013915789
P84077;P61204ARF1_HUMAN5.4085798260.0001193760.013915789
Q13155AIMP2_HUMAN5.4726314540.0001070130.013915789
Q86×67NUD13_HUMAN5.5434412969.49E−050.013915789
O14744ANM5_HUMAN5.3476037980.0001325390.014420204
P62269RS18_HUMAN5.1617789270.0001828730.015924926
Q14444CAPR1_HUMAN5.1894302370.0001742670.015924926
Q15185TEBP_HUMAN5.1539158820.00018540.015924926
Q16629;Q16629-2;Q16629-3SRSF7_HUMAN5.1772713660.0001779980.015924926
P63241-2IF5A1_HUMAN5.0022964480.000241970.018804551
Q99877;O60814;P58876;P62807;Q96A08H2B1N_HUMAN5.0037369730.0002413550.018804551
P46777RL5_HUMAN4.9131102560.0002834090.020109696
Q15008PSMD6_HUMAN4.9315657620.0002742650.020109696
P35232PHB_HUMAN4.813645840.0003384620.023015425
P20645MPRD_HUMAN4.7682652470.0003671720.023566613
P35268RL22_HUMAN4.7558670040.0003754480.023566613